Search research articles
Contact Us
Filters
Showing results (241-250 of 279) with videos related to
Page
of 28
Sort By:
Lancet (London, England)
|
August 7, 1993
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease
N K Boughton-Smith, S M Evans, C J Hawkey, et al.
Gut
|
September 1, 1985
Intravenous omeprazole rapidly raises intragastric pH
R P Walt, J R Reynolds, M J Langman, et al.
Gut
|
January 1, 1993
Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis
A B Hawthorne, C O Record, C D Holdsworth, et al.
Gastroenterology
|
January 29, 1999
Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers
A S Taha, S Dahill, C Morran, et al.
Alimentary Pharmacology & Therapeutics
|
May 8, 1999
Protection against aspirin-induced human gastric mucosal injury by bosentan, a new endothelin-1 receptor antagonist
A E Duggan, W Stack, M Hull, et al.
Infection and Immunity
|
November 1, 1993
Roles of leukotriene B4, prostaglandin E2, and cyclic AMP in Campylobacter jejuni-induced intestinal fluid secretion
P H Everest, A T Cole, C J Hawkey, et al.
Lancet (London, England)
|
April 3, 1993
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy
M A Hull, J Rawlings, F E Murray, et al.
The New England Journal of Medicine
|
March 12, 1998
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group
N D Yeomans, Z Tulassay, L Juhász, et al.
Alimentary Pharmacology & Therapeutics
|
March 22, 2007
Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs
C J Hawkey, R H Jones, N D Yeomans, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2001
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
G F Longstreth, C J Hawkey, E A Mayer, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 279) with videos related to
Sort By:
Page
of 28
Lancet (London, England)
|
August 7, 1993
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease
N K Boughton-Smith, S M Evans, C J Hawkey, et al.
Gut
|
September 1, 1985
Intravenous omeprazole rapidly raises intragastric pH
R P Walt, J R Reynolds, M J Langman, et al.
Gut
|
January 1, 1993
Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis
A B Hawthorne, C O Record, C D Holdsworth, et al.
Gastroenterology
|
January 29, 1999
Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers
A S Taha, S Dahill, C Morran, et al.
Alimentary Pharmacology & Therapeutics
|
May 8, 1999
Protection against aspirin-induced human gastric mucosal injury by bosentan, a new endothelin-1 receptor antagonist
A E Duggan, W Stack, M Hull, et al.
Infection and Immunity
|
November 1, 1993
Roles of leukotriene B4, prostaglandin E2, and cyclic AMP in Campylobacter jejuni-induced intestinal fluid secretion
P H Everest, A T Cole, C J Hawkey, et al.
Lancet (London, England)
|
April 3, 1993
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy
M A Hull, J Rawlings, F E Murray, et al.
The New England Journal of Medicine
|
March 12, 1998
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group
N D Yeomans, Z Tulassay, L Juhász, et al.
Alimentary Pharmacology & Therapeutics
|
March 22, 2007
Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs
C J Hawkey, R H Jones, N D Yeomans, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2001
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
G F Longstreth, C J Hawkey, E A Mayer, et al.
Page
of 28